Instil Bio, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Nov. 03, 2022 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Instil Bio, Inc. (“Instill Bio”) (NASDAQ: TIL) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Instill Bio stock. Instill Bio investors are encouraged to contact the firm to discuss their legal rights.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The investigation focuses on whether the Company misled investors regarding a clinical trial of ITIL-168. Instil Bio disclosed on October 31, 2022, that it had informed the FDA that it had voluntarily paused enrollment in a clinical trial due to problems in manufacturing one of its therapies. The manufacturing trouble resulted in an inability to properly dose patients in a clinical trial of ITIL-168 for advanced melanoma. Based on this news, shares of Instil Bio fell by more than 33% in intraday trading.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
[email protected]
310-692-8883
www.portnoylaw.com
Attorney Advertising
